Ethyl butylacetylaminopropionate:Exports & Compliance White Paper 2026

I. Executive Summary

Ethyl butylacetylaminopropionate (CAS 52304-36-6), known industrially as IR3535 and by INCI name Ethyl Butylacetylaminopropionate, is a synthetic insect repellent active substance of the β-alanine ester class. Developed as a low-odour, plastic- and skin-compatible alternative to older repellents, it is used against mosquitoes, ticks, biting midges and other haematophagous arthropods in personal repellent products and in treated textiles and outdoor articles.

The commercial question in 2026 is not whether IR3535 works but whether each product is authorised. In the EU it is governed by the Biocidal Products Regulation for product type 19. In the United States it is regulated by EPA under FIFRA, with status verified formulation by formulation; in China it requires pesticide registration as a public-health insecticide. Repellent claims are permitted only within approved labels, and no disease-prevention claim is available.

Technically, IR3535 is produced by building the N-butyl-β-alanine ethyl ester skeleton and acetylating the nitrogen, followed by fractional distillation to control colour, odour and residual amines. This white paper addresses manufacturers, formulators and compliance officers sourcing IR3535 as a B2B active substance and provides no medical, public-health efficacy or consumer usage guidance.

II. Product Deep Dive: Molecular Mechanisms and Production Evolution

2.1 Physicochemical Properties and Mechanisms

IR3535 is the ethyl ester of N-butyl-N-acetyl-β-alanine, formula weight about 215.3 g/mol, supplied as a colourless to pale yellow liquid with a mild characteristic odour. It is miscible with ethanol, isopropanol, esters and glycols and has limited solubility in water, which is why it is normally formulated in alcoholic or emulsion bases.

• Repellency mechanism and spectrum: IR3535 acts primarily through olfactory interference: it reduces the attractiveness of a treated surface to host-seeking arthropods rather than killing them, so products are positioned as repellents, not insecticides. Its spectrum covers mosquitoes including Aedes and Anopheles species, ticks and biting midges, with efficacy dependent on dose, formulation and substrate.
• Solvency, compatibility and sensory profile: A distinctive commercial advantage is solvent behaviour: IR3535 helps dissolve other actives and fragrance components. That simplifies formulation but requires compatibility testing with packaging polymers. Its low odour and low skin irritation potential support leave-on personal products. Conversely, it can attack certain plastics and rubber, so closures and gaskets must be qualified against the finished formulation.

2.2 Synthesis and Manufacturing Technologies

Industrial production starts from the β-alanine ester skeleton. Ethyl 3-aminopropanoate is built either by esterification of β-alanine with ethanol or by conjugate addition of n-butylamine to ethyl acrylate, which installs the N-butyl substituent in one step; the secondary amine is then acetylated with acetic anhydride or acetyl chloride to give the tertiary amide ester.

• Acetylation control and odour management: Odour is the most common customer complaint and traces to unconverted amine, residual acetic acid and trace amides or esters formed at distillation temperatures. Producers therefore control the acetylation stoichiometry, quench and wash thoroughly, and use short-path or molecular distillation with low residence time to limit thermal degradation.
• Purity control and the amide rotamer issue: Commercial specification is typically a high single-figure assay with limits on moisture, acidity, residual solvent and colour. A recurring analytical pitfall is that the tertiary amide exists as rotational conformers, so gas chromatographic analysis can show more than one peak for a chemically pure sample; this must not be misreported as an impurity.

2.3 Core Application Matrix

• Skin-applied personal repellents: The dominant outlet is leave-on repellent products: pump sprays, aerosols, lotions, gels, roll-ons and wipes against mosquitoes and ticks. Formulators select IR3535 where low odour and cosmetic acceptability matter. These products are regulated as biocides or pesticides depending on jurisdiction.
• Treated textiles and outdoor articles: IR3535 is applied to clothing, nets, gaiters, wristbands and camping textiles, either by impregnation during manufacture or by consumer-applied treatment. Treated-article rules are jurisdiction-specific: in the EU, articles treated with a biocidal active substance are subject to the treated-article provisions of the Biocidal Products Regulation, including labelling obligations where a repellent claim is made.
• Formulation intermediates and blended systems: IR3535 is also used in combination systems with other repellent actives and with insecticides in public-health and vector-management formulations, and as a solvent-assisting component in fragrance-containing bases. Institutional and public-health procurement typically references WHO evaluation of repellent actives and WHO guidance on efficacy testing of mosquito repellents for human skin, so current WHO status should be verified alongside national registrations.

III. Global Market Supply-Demand Landscape and Export Trends

3.1 Demand Drivers and Market Shifts

Demand is structurally seasonal and public-health-linked: mosquito seasons in Europe and North America, Aedes-borne disease campaigns in tropical markets, and tick and outdoor-recreation exposure in temperate regions. Institutional procurement by public-health agencies and military and occupational buyers sits alongside retail consumer brands, and the two channels have very different documentation requirements.

3.2 Capacity Distribution and Export Flows

Production is concentrated among a small number of speciality producers in Europe and East Asia serving formulation customers worldwide, because the molecule requires amide-ester chemistry and careful distillation rather than commodity capacity. Formulation and filling capacity is far more widely distributed, sitting close to consumer markets.

3.3 Market Bifurcation and Pricing Dynamics

IR3535 trades at a premium to commodity repellent actives, justified by low odour, skin compatibility and the regulatory dossier behind it. Cost is driven by acrylate and butylamine feedstocks, acetic anhydride, energy for vacuum distillation and the cost of maintaining authorisations and dossiers in each market.

IV. In-depth Analysis of Global Compliance and Regulatory Barriers

IR3535 is a biocidal and pesticidal active substance, and the regulatory question always precedes the commercial one: is the active substance approved or registered for the relevant product type in the destination market, is the finished product authorised, and is the supplier on the required list. Because status varies by jurisdiction and by formulation, a supplier's assertion of global approval should never be accepted without verification against the official register.

4.1 European Market: REACH, CLP, and Sector-Specific Directives

• Biocidal Products Regulation (EU) 528/2012 and PT19: In the EU, IR3535 falls under Regulation (EU) 528/2012 for product type 19, repellents and attractants. Placing a biocidal product on the market requires that the active substance be approved for PT19 and, in practice, that the supplier appear on the Article 95 list for that product type, and then that the finished product obtain authorisation — national, Union or simplified — with an approved label and summary of product characteristics.
• Treated articles, cosmetics interface and CLP: Where IR3535 is incorporated into clothing, nets or outdoor gear, the treated-article provisions of the same Regulation apply, including the requirement that claims be supported and that labelling identify the biocidal function. Products making only cosmetic claims while functioning as repellents risk being treated as biocides, so claims must be drafted carefully.

4.2 North American Market: TSCA, EPA, and FDA Regulations

• EPA regulation under FIFRA and minimum-risk status: In the United States IR3535 is regulated by EPA under FIFRA as a pesticide active substance. Depending on the product it may be sold under a full EPA registration with an approved label and establishment number, or a specific formulation may qualify for the FIFRA section 25(b) minimum-risk exemption, which applies only to products whose active and inert ingredients appear on the prescribed lists and which meet strict formulation and labelling conditions.
• Efficacy data, labelling and advertising limits: US labels and advertising are limited to claims supported by the approved label and by accepted efficacy testing; protection-time claims require data generated to recognised protocols, and claims implying prevention of disease are not available for a repellent product of this class. Distributors must also maintain establishment numbers, pesticide producer records and child-resistant packaging where applicable.

4.3 The Critical Hurdle: Quality Control and Safety Limits

V. Green Trade Barriers and ESG in Manufacturing

ESG scrutiny of repellent actives focuses on environmental fate and non-target toxicity rather than on carbon footprint, because volumes are small and applications dispersive. IR3535 is assessed for aquatic toxicity, persistence and bioaccumulation as part of its biocidal approval, and customers increasingly ask for the underlying ecotoxicology dossier, for solvent and waste management at the distillation step, and for packaging-reduction commitments in consumer-filled formats.

5.1 Carbon Footprint and Circular Economy

Production volumes are modest, so absolute emissions are low; the footprint is concentrated in vacuum distillation energy, solvent recovery and the acetic anhydride and acrylate value chains. Practical abatement includes heat integration and high-efficiency vacuum systems, solvent recovery from wash and quench streams, and recovery or responsible destruction of acetic acid by-product.

5.2 Sustainable Sourcing and Traceability

Traceability requirements are regulatory rather than voluntary: biocidal and pesticide supply chains must be able to demonstrate which active-substance source was used in each product batch and that the source is on the required list. Buyers should require the active-substance manufacturer's identity, lot coding carried through formulation and filling, retained samples and certificates of analysis that reference the approved specification, including purity and any maximum limits on impurities of concern.

VI. Supply Chain Resilience and Export Logistics

IR3535 is a liquid active substance with a mild odour, low volatility and good hydrolytic stability, so logistics risk is dominated by packaging compatibility, leakage and cleanliness rather than by hazard class. It is normally transported in lined steel drums, high-density polyethylene drums or intermediate bulk containers, and it attacks some plastics and elastomers, so closure, gasket and liner materials must be qualified.

6.1 Packaging Standards and Moisture/Contamination Control

• Packaging compatibility and closure selection: Because the active is a good solvent, packaging selection is a technical decision: high-density polyethylene, polypropylene, lined steel and, for smaller lots, glass or fluorinated containers are typical, while unqualified elastomer gaskets and certain rigid plastics can swell or stress-crack. Buyers should require compatibility data for the full packaging system including closure liner and, for intermediate bulk containers, the valve and gasket materials.
• Cleanliness, segregation and lot integrity: Formulation customers cannot tolerate odour or colour carry-over, so dedicated or validated cleaning between campaigns, filtered transfer and documented line clearance are required. Material should be segregated from food and feed ingredients and from oxidising agents, stored in bunded areas with spill containment, and handled under local exhaust.

6.2 Dangerous Goods Identification and Transit Protocols

Transport classification depends on the aquatic hazard entry in force for the supplied grade: many commercial grades move as non-regulated liquids, but where the classification triggers the environmentally hazardous substance criteria, UN3082, Class 9, Packing Group III and marine pollutant provisions under the IMDG Code, ADR, RID and IATA Dangerous Goods Regulations come into play. Shippers must therefore confirm the classification and the corresponding SDS before booking, and must not assume non-regulated status.

VII. Enterprise Global Expansion Strategy Guide

Success with IR3535 is a regulatory and documentation exercise supported by chemistry, not the reverse; the molecule is mature, and the differentiator is the dossier behind it.

1. Verify authorisation before commercial terms: Confirm PT19 approval and conditions, the Article 95 listing, the finished product's authorisation route, or the US registration or documented minimum-risk position for the exact formulation. Build the contract around verified register entries, and require the supplier to notify any change in approval status or expiry.
2. Specify odour, residual amine and analytical convention: Technical specifications should cover assay, moisture, acidity, colour, residual butylamine and acetic acid, and an agreed odour assessment, plus the integration convention for amide rotational conformers in gas chromatography. These are the parameters that generate customer complaints.
3. Support formulation with regulatory documentation: Supply the technical dossier, ecotoxicology summaries, SDS in the destination language, and labelling and claim guidance limited to approved wording. Formulators who receive usable regulatory support will consolidate their active-substance sourcing with that supplier.

VIII. Conclusion

IR3535 is a mature, well-characterised repellent active whose commercial future depends almost entirely on regulatory positioning. Its technical advantages — low odour, good solvency, hydrolytic stability and material compatibility — are durable, but they cannot compensate for an unverified authorisation status, and in this market an incorrect claim about exemption or approval is more damaging than any specification defect.

For buyers and formulators, the agenda is clear: verify active-substance approval and supplier listing against official registers, obtain authorisation for each finished product, keep claims within approved label wording, and control the specification parameters that actually cause complaints. For suppliers, the agenda is dossier maintenance, change control and regulatory support.

IX. Industry Resource Connection and Supplier Ecosystem

Powered by Guidechem

This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.

Guidechem Global Ethyl butylacetylaminopropionate (IR3535) Supplier Ecosystem List

Relying on Guidechem's extensive global database, we have mapped the core participants in the current global Ethyl butylacetylaminopropionate (IR3535) supply chain:

• European Union — PT19 active substance and biocidal dossiers: The EU ecosystem centres on the active-substance manufacturer and the downstream formulators holding product authorisations under Regulation (EU) 528/2012, with Germany historically the origin and regulatory home of IR3535. Participants compete on dossier depth, Article 95 listing, support for national and Union authorisations, and technical service to consumer-brand formulators. Buyers sourcing for EU markets essentially buy regulatory support together with the molecule.
• United States — FIFRA registrations and consumer brands: The US market is organised around EPA registrations under FIFRA, with registrants holding approved labels and, for certain formulations, minimum-risk positions that must be verified formulation by formulation. Consumer repellent brands, outdoor and sporting-goods companies and institutional buyers drive demand, supported by registrants that maintain efficacy data and state registrations.
• China — production capacity and public-health insecticide registration: Chinese producers supply technical material and a growing share of finished hygiene-insecticide formulations, and domestic placement requires pesticide registration for public-health insecticides under the national pesticide regulatory framework, including registration of imported products through a local agent. Regional manufacturers supply mosquito-repellent consumer formats and treated-textile applications across Asia.